It is disclosed a method of producing a food product for human consumption by using extrusion from a plant-based food material and gutted and plucked poultry comprising bones, hard tissues, tendons, skin and/or cartilages.

According to the invention, it was found that, surprisingly, a feedstuff having a very high abrasion resistance and very high water stability can be obtained when a PUFA-containing biomass having a high sulphate content is used for producing the feedstuff.

According to the invention, it was found that, surprisingly, a feedstuff having a very high abrasion resistance and very high water stability can be obtained when a PUFA-containing biomass having a high sulphate content is used for producing the feedstuff.

The present disclosure relates to a low-density dry food composition having a penetration rate of at least about 30% and comprising at least, by weight relative to the total weight of said composition: a. a protein source in an amount ranging from about 15% to about 30%, b. fat in an amount ranging from about 5% to about 15%, c. starch in an amount ranging from about 35% to about 5% and d. a total dietary fibers source in an amount ranging from about 3% to about 12%. The disclosure also relates to methods of use for improving oral hygiene, and methods for manufacturing said disclosure.

The invention concerns the method and the use of an antimicrobial composition consisting of: (i) at least 30% of lactic acid, and (ii) at least two carboxylic acids selected from the group consisting of acetic acid, butyric acid, isobutyric acid, valeric acid, and isovaleric acid for providing an antimicrobial activity against one or more undesired microorganisms to a pet food product.

The present disclosure is directed to processed animal food and/or treat that includes undenatured type II collagen. The undenatured type II collagen is introduced to the animal food and/or treat prior to processing, and at least 30% or more of the undenatured collagen remains undenatured in the after processing the animal food and/or treat.

The present disclosure is directed to processed animal food and/or treat that includes undenatured type II collagen. The undenatured type II collagen is introduced to the animal food and/or treat prior to processing, and at least 30% or more of the undenatured collagen remains undenatured in the after processing the animal food and/or treat.

A chew resistant dog toy securely contains and retains a replaceable lickable treat. The toy facilitates the predictable, gradual, and prolonged ingestion of the treat by an animal's licking of an available surface of the lickable treat. The dog toy has a chew resistant body (typically made of a tough polymer or a hard rubber material) and a channel having an elongated opening along a major surface of the toy. The channel is adapted to receive and securely hold and retain the treat. The treat may or may not contain one or more active ingredients that are useful for promoting a calming effect on the dog, including active agents (such as theanine, Relora, SAMe, GABA, ashwagandha, tryptophan, turmeric, Boswellia serrata, panax ginseng, Methylsulfonylmethane, 5-HTP, etc.), other botanicals that facilitate sleep and relaxation (such as Valerian root, Chamomile, Lemon balm, Passion flower, Kavakava, Tulsi-Holy basil (Ocimum tenuiflorum)) and cannabinoids (such as CBD, CBN, etc.).

Methods of detecting the presence of one copy or 2 copies of a minor allele of one or more single nucleotide polymorphisms selected from the group consisting of SNP A3_117040611, SNP A3_117041908 and SNP A3_117081913 are disclosed. Methods of identifying a feline subject as being at an increased likelihood of developing cat kidney disease are disclosed. Methods of monitoring the health of a feline subject identified as having an increased likelihood of developing CKD are provided. Methods of monitoring the health of a feline subject and response to treatment for renal disease that comprise quantifying at 2PY present are provided. Methods of delaying onset and severity of cat kidney disease in a feline subject identified as having an increased likelihood of developing CKD and methods of treating cats that have CKD are provided.

Dispersion type feed additive compositions for ruminants, containing (A) at least one selected from hydrogenated vegetable oil and hydrogenated animal oil each having a melting point of higher than 50° C. and lower than 90° C., (B) not less than 0.01 wt % and not more than 6 wt % of a surfactant, (C) not less than 16 wt % and not more than 72 wt % of a biologically active substance (excluding L-lysine and a salt thereof), and (D) not less than 1 wt % and not more than 40 wt % of L-lysine or a salt thereof, contain a biologically active substance at a high concentration, show high protection in the rumen, and are also superior in dissolution in the intestinal tract.